Cargando…

The impacts of the National Medication Price-Negotiated Policy on the financial burden of cancer patients in Shandong province, China: an interrupted time series analysis

BACKGROUND: In order to further regulate the price of anticancer medication and alleviate the financial burden of cancer patients, the Chinese government implemented the National Medication Price-Negotiated Policy (NMPNP) in 2017. This study aims to assess the impacts of implementation of the NMPNP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yi, Zheng, Chao, Wei, Xiaolin, Zhang, Qi, Sun, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756446/ https://www.ncbi.nlm.nih.gov/pubmed/36527037 http://dx.doi.org/10.1186/s12889-022-14525-7

Ejemplares similares

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study
por: Cai, Lele, et al.
Publicado: (2022)

Impacts of National Drug Price Negotiation on Expenditure, Volume, and Availability of Targeted Anti-Cancer Drugs in China: An Interrupted Time Series Analysis
por: Sun, Yan, et al.
Publicado: (2022)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
por: Zhu, Hong, et al.
Publicado: (2022)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Hospitalization Costs and Financial Burden on Families with Children with Depression: A Cross-Section Study in Shandong Province, China
por: Guo, Yawei, et al.
Publicado: (2019)

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis
por: Hu, Shuchen, et al.
Publicado: (2019)

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis
por: Zhao, Mingyue, et al.
Publicado: (2021)

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
por: Wang, Ni, et al.
Publicado: (2021)

A Cross-Sectional Study of Price and Affordability of Drugs for Rare Diseases in Shandong Province, China
por: Mu, Yan, et al.
Publicado: (2022)

Antibiotic Expenditure by Public Healthcare Institutions in Shandong Province in China, 2012–2016
por: Yin, Jia, et al.
Publicado: (2018)

Epidemiological Characteristics of Human Rabies — Shandong Province, China, 2010–2020
por: Zhang, Xiaomei, et al.
Publicado: (2022)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Cysticercosis in Shandong Province, Eastern China
por: Liu, Gongzhen, et al.
Publicado: (2018)

Evaluating Family Planning Organizations Under China’s Two-Child Policy in Shandong Province
por: Xu, Lizheng, et al.
Publicado: (2019)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

Epidemiological analysis of injury in Shandong Province, China
por: Ma, Jixiang, et al.
Publicado: (2008)

Two Confirmed Patients of Anthrax — Binzhou City, Shandong Province, China, August 2021
por: Yu, Xiaolin, et al.
Publicado: (2021)

Negotiating prices of drugs for rare diseases
por: Henrard, Séverine, et al.
Publicado: (2016)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis
por: Liu, Yanyan, et al.
Publicado: (2022)

Epidemiological characteristics and spatio-temporal analysis of brucellosis in Shandong province, 2015–2021
por: Yu, Xiaolin, et al.
Publicado: (2023)

Investigation on an outbreak of cutaneous anthrax in a county of Shandong Province, China, 2021
por: Yu, Xiaolin, et al.
Publicado: (2022)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
por: Wu, Di, et al.
Publicado: (2022)

Clinical Characteristics and Visual Outcomes of Patients Hospitalized for Ocular Trauma in Shandong Province, China
por: Duan, Fangnan, et al.
Publicado: (2020)

Epidemiological and time series analysis of haemorrhagic fever with renal syndrome from 2004 to 2017 in Shandong Province, China
por: Zhang, Chao, et al.
Publicado: (2019)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Predictors of negotiated prices for new drugs in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
por: Mingge, Xia, et al.
Publicado: (2023)

The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China
por: Bao, Yuwen, et al.
Publicado: (2023)

Genetic Diversity and the Spatio-Temporal Analyses of Hantaviruses in Shandong Province, China
por: Zuo, Shu-Qing, et al.
Publicado: (2018)

Case report: One human Streptococcus suis occurred in Shandong Province, China
por: Chen, Shuyu, et al.
Publicado: (2022)

Case report: One human Streptococcus suis infection in Shandong Province, China
por: Liu, Yuwei, et al.
Publicado: (2023)

Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China
por: Du, Wenjun, et al.
Publicado: (2020)

Comparison of US Hospital Cash Prices and Commercial Negotiated Prices for 70 Services
por: Jiang, John (Xuefeng), et al.
Publicado: (2021)

Severe Fever with Thrombocytopenia Syndrome Virus, Shandong Province, China
por: Zhao, Li, et al.
Publicado: (2012)

Coxsackievirus B3, Shandong Province, China, 1990–2010
por: Tao, Zexin, et al.
Publicado: (2012)

Severe Fever with Thrombocytopenia Syndrome, Shandong Province, China, 2011
por: Wen, Hong-Ling, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3scdn5bhm1qlmla9p07eig1f51